Turnkey Process Systems — Single-Source Design, Build & Validate

Because of what happens when something fails a test. On a split scope a failed result produces a discussion about whose scope it was; on a single contract it produces a repair. Concretely: passivation verification missing from a package, steam quality failing at OQ with the validation firm reporting and the piping contractor disputing design intent, a cleaning circuit where the skid vendor blames the circuits and the piping contractor blames the skid, or IQ stalling because documents sit with four different parties.

Ask what is actually self-performed rather than brokered, because many firms describe themselves as single-source while subcontracting welding, passivation or both. Require the in-house scope to be listed in the contract rather than the capability statement. Establish in writing who corrects a failed qualification test. Confirm one turnover package indexed to your IQ checklist and described before work begins. And ask for references where something went wrong and how it was resolved, since that is what you are actually buying.

Evidence an inspector will accept, delivered in a form qualification can consume: weld maps and logs with welder qualifications and coupons, material test reports traceable by heat number, slope and drainability verification, passivation procedure with contact time and verification results, pressure and examination test records, and instrument calibration certificates traceable to national standards. Critically, all of it indexed to the IQ checklist and described before work starts, because documentation assembled retroactively is the most common cause of qualification delay.

A system they can own for a decade. That means as-built drawings genuinely reconciled to what was installed rather than the design drawings re-issued, components sited where they can actually be reached and serviced, full drainability, a spares list for wear items such as gaskets, diaphragms and traps, and no design that requires heroics to maintain. The common failure is valves and instruments positioned for the convenience of installation rather than for the decade of maintenance that follows.

Require the implicit scope to be made explicit, because that is what makes bids incomparable. Specifically: the examination level and who judges acceptance, the depth of the documentation package and its index to the IQ checklist, whether passivation is in-house and to which standard, what is self-performed versus brokered, and contractually who corrects a failed qualification test. Two bids for identical pipework can differ substantially on those points alone, and the cheaper one is usually the one examining and documenting less.

Thermal expansion. A joint tightened cold on a run that has not yet seen process temperature will move as the system heats, and a pressure test performed cold does not reproduce that. Re-checking joints after the first thermal cycle should be a routine step rather than a reaction to a leak, and it is much cheaper than discovering it during wet commissioning with the plant waiting.

Utilities and documentation, rather than the equipment. Capacity assumed at design but never confirmed at peak demand, and documentation assembled retroactively rather than produced as work proceeded, between them account for most delay. Both are predictable at design review, which is why start-up failures are better described as untested assumptions surfacing than as new problems appearing.

Pharmaceutical facility construction is delivered under several different models and the model matters more than the firm. Design-bid-build separates designer and builder, giving price competition but placing coordination risk on the owner. Design-build puts both under one contract, which shortens schedule and reduces interface disputes but requires more owner definition up front. Engineering, procurement and construction management suits large capital programmes. Specialist process contractors deliver the process systems inside a base building someone else erects, which is the most common arrangement for retrofits and expansions. Decide the model before shortlisting, then screen on whether the candidate has delivered a facility that was subsequently inspected successfully, since construction quality and regulatory outcome are different tests.

The governing framework in the United States is cGMP under 21 CFR 210 and 211, which requires facilities of suitable design, size, construction and location, with adequate separation of operations, controlled environments where required, and utilities that do not contaminate product. FDA guidance on aseptic processing applies to sterile manufacture, and EU GMP Annex 1 applies if product is destined for Europe. Beyond that sit the engineering standards those expectations are met through: ISO 14644 for cleanroom classification, ASME BPE for hygienic systems, USP monographs for compendial water. Layered on top are conventional building, fire, electrical and environmental permits, plus DEA registration for controlled substances and NIH Guidelines where recombinant work is involved.

What distinguishes project management on a regulated build is that the schedule has a qualification tail nobody can compress. The critical path near the end is not mechanical completion but commissioning, qualification and, for compendial water, a sampling campaign whose duration is fixed by laboratory incubation. Screen managers on whether they build the schedule backwards from validated release rather than forwards from construction start, whether they integrate commissioning and qualification under an ASTM E2500 approach rather than treating validation as a separate downstream project, and how they handle turnover package assembly, which if left to the end becomes the item that delays occupancy. Ask for a schedule from a completed project showing where qualification actually sat.

Ask questions that expose whether they understand the regulated part. Who assembles the turnover package and when, because a package built at the end from reconstructed records is where projects fail inspection. How commissioning and qualification are integrated with construction rather than sequenced after it. Who owns the pressure cascade across the whole facility, since that is a system property spanning trades. How they protect adjacent operating areas if this is an expansion. What their approach is to change control during construction, because undocumented field changes are what break a qualification package. And ask for a redacted turnover package from a completed facility, since that single document reveals more than any reference visit.

Budget per square foot by area type rather than as a single facility rate, because the mix drives everything. Typical United States figures: general and warehouse space $150 to $350 per square foot; laboratory space $400 to $800; ISO 8 manufacturing $180 to $360; ISO 7 manufacturing $250 to $500; ISO 5 aseptic fill $700 to $1,500; and aseptic fill with barrier systems or isolators $1,500 to $3,000 or more. Process equipment and utilities frequently equal or exceed the building shell. Commissioning and qualification typically add 8 to 15 percent of total project cost. And the schedule carries its own cost, since a compendial water system cannot release water until its multi-week sampling campaign completes.

Five practices separate projects that finish from projects that drift. Define user requirements before design rather than during it, because every qualification test traces back to that document. Integrate commissioning and qualification into the construction programme under a risk-based approach, rather than treating validation as a separate project starting at mechanical completion. Build the turnover package continuously as work is done, since reconstructing weld logs, material certificates and calibration records afterwards is expensive and sometimes impossible. Apply change control from the start of construction, not from handover, because undocumented field changes are the classic cause of a failed qualification. And schedule backwards from validated release, since the qualification tail is calendar time nobody can compress.

Sterile facility architecture is a specialised discipline because the layout itself is a contamination control. What distinguishes a capable firm is how they handle flows: unidirectional personnel and material movement, gowning sequences with the right number of steps for each grade transition, airlock placement, and segregation of clean and dirty routes so they never cross. They should design the pressure cascade across the whole suite as a system rather than room by room. Under the revised EU GMP Annex 1 they should be able to contribute to a Contamination Control Strategy and design for barrier technology rather than open aseptic processing. Ask to see a flow diagram from a completed sterile facility, since that drawing shows immediately whether they think this way.